Praxis Precision Medicines Accounts Payable

Praxis Precision Medicines (PRAX) currently reports a accounts payable of $23M as of June 2026. That compares with $29M in the prior-year period — down 18.9% year over year. Use the charts on this page to explore Praxis Precision Medicines's accounts payable history and peer comparisons.

Praxis Precision Medicines's accounts payable decreased from $29M to $23M — a 18.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Praxis Precision Medicines reported $23M in accounts payable as of June 2026. That compares with $29M in the prior-year period — down 18.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Praxis Precision Medicines, and consider following PRAX for alerts when major investors trade the stock.

Praxis Precision Medicines is classified in the Healthcare sector. On accounts payable, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRAX with unrelated industries.